2 questions lodged at 2025 Arovella Therapeutics virtual EGM
May 8, 2025
Below is the text of the 2 written questions submitted at the 7 minute Arovella Therapeutics (ALA) virtual EGM held via Zoom on May 8, 2025 to approve 2 share placement resolutions raising $15m. See notice of meeting and voting results. Market cap was $100m on AGM day.
Q1. Is a copy of today's webcast going to be made available on the company's webcast for the benefit of thousands of shareholders who were not able to watch live?
Answer: The chair Dr Tom Duthy advised yes. Watch video of exchange via Twitter.
Q2. Why wasn't this meeting run as a hybrid and will the next shareholder meeting be a hybrid?
Answer: The chair Dr Tom Duthy said it was virtual as some directors were based in the US and the next AGM would be either physical or a hybrid. Watch video of exchange via Twitter.
Copyright © 2025 The Mayne Report. All rights reserved
